Sachs 5th Annual Neuroscience Innovation Forum

Other news
Written By Stine Krag Brunvold

We will be participating in the virtual Sachs 5th Annual Neuroscience Innovation Forum from 22-23rd March. On 22 March, our CEO Thomas Holm Pedersen will be taking part in the Rare & Orphan & New Modality Panel, sharing his expertise with a showcase presentation.

Our team will be in attendance and available for meetings and discussions over both days. If you would like to schedule a meeting with us, please contact: contact@nmdpharma.com

You can see all participating attendees here: https://www.sachsforum.com/5nif-attendees.html

We look forward to seeing you there!

Stine Krag Brunvold
Previous

NMD Pharma formår igen at rejse kapital – ser muligheder i bedre offentligt-privat samarbejde
Next

Welcome to David Evans